Today's blog is from John Piears, who lost his wife to cancer last year and went on to set up the Dying for a Cure campaign, to push for much needed reforms of the R&D system for developing and funding new cancer treatments
Barely a month goes by without a newspaper headline claiming that "A cure for all cancers is on the way" or hailing the latest "Major cancer breakthrough", but dig beneath the media hype and you'll discover the shocking reality that new cancer drugs for most cancers are only expected to improve patient survival by just 2.7 months on average, despite costing an estimated £2bn each to develop.
